Follow
Elena Smekalova
Elena Smekalova
Beam therapeutics
Verified email at beamtx.com
Title
Cited by
Cited by
Year
Genome sequence and analysis of methylotrophic yeast Hansenula polymorpha DL1
NV Ravin, MA Eldarov, VV Kadnikov, AV Beletsky, J Schneider, ...
BMC genomics 14, 1-20, 2013
1072013
Computationally guided high-throughput design of self-assembling drug nanoparticles
D Reker, Y Rybakova, AR Kirtane, R Cao, JW Yang, N Navamajiti, ...
Nature nanotechnology 16 (6), 725-733, 2021
702021
Telomerase RNA biosynthesis and processing
EM Smekalova, OS Shubernetskaya, MI Zvereva, EV Gromenko, ...
Biochemistry (Moscow) 77, 1120-1128, 2012
512012
lncRNA in the liver: Prospects for fundamental research and therapy by RNA interference
EM Smekalova, YV Kotelevtsev, D Leboeuf, EY Shcherbinina, AS Fefilova, ...
Biochimie 131, 159-172, 2016
352016
Structural features of the telomerase RNA gene in the naked mole rat Heterocephalus glaber
SA Evfratov, EM Smekalova, AV Golovin, NA Logvina, MI Zvereva, ...
Acta Naturae (англоязычная версия) 6 (2 (21)), 41-47, 2014
212014
On multilabel classification methods of incompletely labeled biomedical text data
A Kolesov, D Kamyshenkov, M Litovchenko, E Smekalova, A Golovizin, ...
Computational and mathematical methods in medicine 2014, 2014
202014
Specific features of telomerase RNA from Hansenula polymorpha
EM Smekalova, AN Malyavko, MI Zvereva, AV Mardanov, NV Ravin, ...
RNA 19 (11), 1563-1574, 2013
192013
TERRA–a calling card for telomerase
E Smekalova, P Baumann
Molecular cell 51 (6), 703-704, 2013
182013
In vivo RNAi-mediated eIF3m knockdown affects ribosome biogenesis and transcription but has limited impact on mRNA-specific translation
EM Smekalova, MV Gerashchenko, PBF O’Connor, CA Whittaker, ...
Molecular Therapy-Nucleic Acids 19, 252-266, 2020
142020
Gene editing technologies to target HBV cccDNA
MG Martinez, E Smekalova, E Combe, F Gregoire, F Zoulim, B Testoni
Viruses 14 (12), 2654, 2022
122022
Hansenula Polymorpha TERT: a telomerase catalytic subunit isolated in recombinant form with limited reverse transcriptase activity
EM Smekalova, OA Petrova, MI Zvereva, OA Dontsova
Acta Naturae (англоязычная версия) 4 (1 (12)), 70-73, 2012
112012
Translation elongation factor 2 depletion by siRNA in mouse liver leads to mTOR-independent translational upregulation of ribosomal protein genes
MV Gerashchenko, MV Nesterchuk, EM Smekalova, JA Paulo, ...
Scientific reports 10 (1), 15473, 2020
102020
Identification of additional telomerase component of the yeast H. polymorpha is a step towards understanding the complex at the atomic level.
O Petrova, E Smekalova, M Zvereva, V Lamzin, O Dontsova
Doklady Biochemistry & Biophysics 455 (1), 2014
52014
Cytosine base editing inhibits hepatitis B virus replication and reduces HBsAg expression in vitro and in vivo
EM Smekalova, MG Martinez, E Combe, A Kumar, S Dejene, D Leboeuf, ...
Molecular Therapy-Nucleic Acids 35 (1), 2024
42024
Isolation of active yeast telomerase protein Est3p and investigation of its dimerization in vitro
YS Sharanov, EM Smekalova, MI Zvereva, OA Dontsova
Biochemistry (Moscow) 72, 702-706, 2007
22007
CCCDNA inactivation using cytosine base editors
MG Martinez, E Smekalova, E Combe, MS Packer, LA Barrera, S Dejene, ...
Hepatology 74, 504A-504A, 2021
12021
Detection of the telomerase activity and identification of the telomerase components in thermotolerant yeast Hansenula polymorpha
EM Smekalova, MI Zvereva, OA Dontsova
FEBS JOURNAL 278, 90-90, 2011
12011
ADENINE BASE EDITING SILENCES HBsAg EXPRESSION AND INHIBITS HEPATITIS B VIRAL REPLICATION IN HBV MOUSE MODELS
EM Smekalova, A Kumar, E Combe, S Dejene, CY Chen, D Leboeuf, ...
HEPATOLOGY 78, S553-S554, 2023
2023
Compositions and methods for treating hepatitis b
E Smekalova, M Packer, F Gregoire, L Barrera, G Ciaramella
US Patent App. 17/610,119, 2023
2023
Compositions and methods for treating hepatitis b
E Smekalova, M Packer, F Gregoire, L Barrera, G Ciaramella
2020
The system can't perform the operation now. Try again later.
Articles 1–20